Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 13th June 2025
Solactive US CNS Therapeutics Index:
In the ordinary adjustment, the following composition will be implemented effective open 13th June 2025:
ACADIA PHARMACEUTICALS INC |
ALKERMES PLC |
ANAVEX LIFE SCIENCES CORP |
AVADEL PHARMACEUTICALS PLC |
AXSOME THERAPEUTICS INC |
BIOGEN INC |
DENALI THERAPEUTICS INC |
ELI LILLY & CO |
HARMONY BIOSCIENCES HOLDINGS INC |
JAZZ PHARMACEUTICALS PLC |
NEUROCRINE BIOSCIENCES INC |
NEW BIOHAVEN |
PTC THERAPEUTICS INC |
Praxis Precision Medicines Inc |
SAREPTA THERAPEUTICS INC |
SCHOLAR ROCK HOLDING CORP |
SUPERNUS PHARMACEUTICALS INC |
UNIQURE B.V. |
VERTEX PHARMACEUTICALS INC |
XENON PHARMACEUTICALS INC |